Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ADUS Addus HomeCare	$114.05 +0.9%	$109.43	$88.96 ▼ $136.72	$2.08B	0.81	171,167 shs	214,521 shs
FLGT Fulgent Genetics	$19.52 +1.0%	$19.86	$14.57 ▼ $25.11	$588.47M	1.06	285,845 shs	144,903 shs
LFST LifeStance Health Group	$5.08 +2.4%	$5.89	$4.64 ▼ $8.61	$1.93B	1.22	1.64 million shs	3.23 million shs
VCYT Veracyte	$26.88 +0.6%	$28.78	$19.73 ▼ $47.32	$2.09B	2.09	904,004 shs	534,867 shs

A Beginner's Guide to Investing in Cannabis

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ADUS Addus HomeCare	-0.69%	-1.25%	+0.76%	+18.95%	-4.59%
FLGT Fulgent Genetics	-1.02%	-7.69%	-4.83%	+13.37%	-4.64%
LFST LifeStance Health Group	+2.69%	-4.06%	-9.65%	-26.74%	-6.24%
VCYT Veracyte	+1.21%	+0.26%	-1.66%	-20.72%	+18.50%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ADUS Addus HomeCare	4.6825 of 5 stars	3.6	2.0	5.0	2.7	2.5	1.9
FLGT Fulgent Genetics	3.9404 of 5 stars	2.3	4.0	4.1	2.0	3.3	0.6
LFST LifeStance Health Group	2.6202 of 5 stars	3.4	2.0	0.0	2.5	2.5	0.6
VCYT Veracyte	3.5481 of 5 stars	3.4	1.0	4.3	2.8	0.0	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ADUS Addus HomeCare	3.25	Buy	$142.57	25.01% Upside
FLGT Fulgent Genetics	2.50	Moderate Buy	$24.00	22.95% Upside
LFST LifeStance Health Group	2.83	Moderate Buy	$8.50	67.32% Upside
VCYT Veracyte	2.70	Moderate Buy	$40.90	52.16% Upside

Current Analyst Ratings Breakdown

Latest FLGT, ADUS, VCYT, and LFST Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/20/2025	ADUS Addus HomeCare	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Outperform	$150.00
6/10/2025	ADUS Addus HomeCare	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$133.00
5/27/2025	LFST LifeStance Health Group	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$8.50
5/8/2025	ADUS Addus HomeCare	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$129.00 ➝ $133.00
5/8/2025	VCYT Veracyte	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$49.00 ➝ $42.00
5/8/2025	VCYT Veracyte	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$51.00 ➝ $41.00
5/6/2025	FLGT Fulgent Genetics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$16.00 ➝ $23.00
5/5/2025	FLGT Fulgent Genetics	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$24.00 ➝ $25.00
4/22/2025	ADUS Addus HomeCare	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Outperform	$150.00 ➝ $150.00
4/10/2025	ADUS Addus HomeCare	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Outperform	$150.00 ➝ $150.00
4/9/2025	VCYT Veracyte	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$45.00 ➝ $37.00

(Data available from 6/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ADUS Addus HomeCare	$1.15B	1.82	$5.44 per share	20.97	$53.52 per share	2.13
FLGT Fulgent Genetics	$283.47M	2.10	N/A	N/A	$36.92 per share	0.53
LFST LifeStance Health Group	$1.25B	1.58	$0.04 per share	125.08	$3.78 per share	1.34
VCYT Veracyte	$445.76M	4.72	$1.04 per share	25.76	$15.17 per share	1.77

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ADUS Addus HomeCare	$73.60M	$4.43	25.74	21.28	1.60	6.52%	9.23%	6.96%	8/4/2025 (Estimated)
FLGT Fulgent Genetics	-$42.71M	-$1.33	N/A	N/A	N/A	-13.94%	-2.19%	-2.02%	8/1/2025 (Estimated)
LFST LifeStance Health Group	-$57.44M	-$0.10	N/A	N/A	N/A	-2.78%	-2.47%	-1.69%	8/14/2025 (Estimated)
VCYT Veracyte	$24.14M	$0.41	65.56	37.33	N/A	7.13%	6.14%	5.60%	8/5/2025 (Estimated)

Latest FLGT, ADUS, VCYT, and LFST Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
5/5/2025	Q1 2025	ADUS Addus HomeCare	$1.33	$1.42	+$0.09	$1.16	$341.66 million	$337.71 million
5/2/2025	Q1 2025	FLGT Fulgent Genetics	-$0.18	$0.04	+$0.22	-$0.37	$71.26 million	$73.46 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ADUS Addus HomeCare	N/A	N/A	N/A	N/A	N/A
FLGT Fulgent Genetics	N/A	N/A	N/A	N/A	N/A
LFST LifeStance Health Group	N/A	N/A	N/A	N/A	N/A
VCYT Veracyte	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ADUS Addus HomeCare	0.20	1.74	1.74
FLGT Fulgent Genetics	N/A	6.32	6.32
LFST LifeStance Health Group	0.19	1.47	1.47
VCYT Veracyte	N/A	5.10	4.78

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ADUS Addus HomeCare	95.35%
FLGT Fulgent Genetics	48.06%
LFST LifeStance Health Group	85.50%
VCYT Veracyte	N/A

Insider Ownership

Company	Insider Ownership
ADUS Addus HomeCare	4.60%
FLGT Fulgent Genetics	33.11%
LFST LifeStance Health Group	6.60%
VCYT Veracyte	1.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ADUS Addus HomeCare	49,703	18.40 million	17.55 million	Optionable
FLGT Fulgent Genetics	1,313	30.44 million	20.36 million	Optionable
LFST LifeStance Health Group	10,218	388.88 million	363.21 million	Optionable
VCYT Veracyte	790	78.32 million	77.22 million	Optionable

FLGT, ADUS, VCYT, and LFST Headlines

Recent News About These Companies

Veracyte, Inc. (NASDAQ:VCYT) Receives Average Rating of "Moderate Buy" from Analysts

June 23 at 2:10 AM | marketbeat.com

Veracyte (NASDAQ:VCYT) shareholders have earned a 19% return over the last year

June 20, 2025 | finance.yahoo.com

GAMMA Investing LLC Purchases 18,840 Shares of Veracyte, Inc. (NASDAQ:VCYT)

June 19, 2025 | marketbeat.com

Cathie Wood’s ARK buys BWX stock, sells Adaptive Biotech

June 18, 2025 | investing.com

Exchange Traded Concepts LLC Increases Stake in Veracyte, Inc. (NASDAQ:VCYT)

June 17, 2025 | marketbeat.com

Veracyte (NASDAQ:VCYT) Rating Increased to Buy at Wall Street Zen

June 15, 2025 | americanbankingnews.com

Veracyte, Inc. (NASDAQ:VCYT) Shares Purchased by Assenagon Asset Management S.A.

June 14, 2025 | marketbeat.com

Veracyte (NASDAQ:VCYT) Stock Rating Upgraded by Wall Street Zen

June 14, 2025 | marketbeat.com

Veracyte (NASDAQ:VCYT) Shares Down 4.8% - Should You Sell?

June 12, 2025 | marketbeat.com

Veracyte (VCYT) Fell Despite Reporting Revenue Growth and Improved Profitability

June 9, 2025 | msn.com

Cathie Wood's Ark Invest Loads Up On Veracyte, Offloads 3D Systems

June 7, 2025 | benzinga.com

Insider Selling: John Leite Sells Shares of Veracyte Inc (VCYT)

June 6, 2025 | gurufocus.com

Veracyte (VCYT) Down 13.6% Since Last Earnings Report: Can It Rebound?

June 6, 2025 | msn.com

Cathie Wood’s ARK sells Palantir and Roblox, buys Veracyte and Guardant

June 4, 2025 | investing.com

Veracyte (VCYT) Shares Pulled Back Despite Beating Expectations

June 3, 2025 | msn.com

Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by AEGON ASSET MANAGEMENT UK Plc

June 3, 2025 | marketbeat.com

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 30,059 Shares of Veracyte, Inc. (NASDAQ:VCYT)

June 2, 2025 | marketbeat.com

Veracyte (NASDAQ:VCYT) Lowered to Hold Rating by Wall Street Zen

June 2, 2025 | marketbeat.com

Quent Capital LLC Has $337,000 Stake in Veracyte, Inc. (NASDAQ:VCYT)

June 1, 2025 | marketbeat.com

Universal Beteiligungs und Servicegesellschaft mbH Purchases New Stake in Veracyte, Inc. (NASDAQ:VCYT)

June 1, 2025 | marketbeat.com

Veracyte, Inc. (NASDAQ:VCYT) Given Average Rating of "Moderate Buy" by Brokerages

May 30, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

FLGT, ADUS, VCYT, and LFST Company Descriptions

Addus HomeCare NASDAQ:ADUS

$114.05 +1.04 (+0.92%)

Closing price 04:00 PM Eastern

Extended Trading

$112.96 -1.10 (-0.96%)

As of 05:59 PM Eastern

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.

Fulgent Genetics NASDAQ:FLGT

$19.52 +0.19 (+0.98%)

Closing price 04:00 PM Eastern

Extended Trading

$19.51 -0.01 (-0.05%)

As of 04:04 PM Eastern

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.

LifeStance Health Group NASDAQ:LFST

$5.08 +0.12 (+2.42%)

Closing price 04:00 PM Eastern

Extended Trading

$5.01 -0.07 (-1.36%)

As of 07:34 PM Eastern

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

Veracyte NASDAQ:VCYT

$26.88 +0.17 (+0.64%)

Closing price 04:00 PM Eastern

Extended Trading

$26.96 +0.08 (+0.31%)

As of 07:59 PM Eastern

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time